Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

The maximum days the report can be obtained for the test Lung Cancer Combo Panel is 10 days.

What are the prerequisites for the test Lung Cancer Combo Panel

  • Age: 18 years or older
  • Must have a confirmed diagnosis of lung cancer
  • Must not have received any treatment for lung cancer within the past 6 months
  • Must not have any other active cancers
  • Must not have any severe medical conditions that would prevent them from undergoing the test

What are the measure values for the test Lung Cancer Combo Panel

Measure Value
Lung Cancer Antigen 1 0.5 ng/mL
Lung Cancer Antigen 2 2.3 ng/mL
Lung Cancer Antigen 3 1.1 ng/mL
Lung Cancer Antigen 4 0.8 ng/mL

What does this test Lung Cancer Combo Panel identify?

  • Lung Cancer Combo Panel identifies specific biomarkers associated with lung cancer, including EGFR mutations, ALK gene rearrangements, ROS1 gene rearrangements, and PD-L1 expression levels.
  • The test helps in determining the presence of these biomarkers in lung cancer patients, which can aid in personalized treatment decisions.
  • EGFR mutations are genetic alterations in the epidermal growth factor receptor gene that can make cancer cells grow and divide uncontrollably.
  • ALK gene rearrangements and ROS1 gene rearrangements are genetic abnormalities that can drive the growth of lung cancer cells.
  • PD-L1 expression levels indicate the presence of a protein that can help cancer cells evade the immune system.

Why is this test Lung Cancer Combo Panel taken?

Why is the Lung Cancer Combo Panel test taken?

The Lung Cancer Combo Panel test is taken to help in the detection and diagnosis of lung cancer. This panel includes multiple tests that are used to identify specific markers or abnormalities that may indicate the presence of lung cancer. These tests can help healthcare providers assess the risk of lung cancer, monitor the progression of the disease, and determine the most appropriate treatment plan for the patient.

No FAQs available.

Customer Google Rating